BackCM Life Sciences Overview

CM Life Sciences Receivables

CM Life Sciences's receivables is $84M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$83.61M
↑ 74.09% YoYΔ $35.58M vs prior year quarter

Peer trimmed avg / median

Loading

CM Life Sciences Receivables History

Loading

CM Life Sciences vs. peers: Receivables Comparison

Loading

CM Life Sciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CM Life Sciences (CMLF) FAQ

CM Life Sciences (CMLF) currently reports a receivables of $84M as of June 2026. That compares with $48M in the prior-year period — up 74.1% year over year. Use the charts on this page to explore CM Life Sciences's receivables history and peer comparisons.

CM Life Sciences's receivables increased from $48M to $84M — a 74.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CM Life Sciences reported $84M in receivables as of June 2026. That compares with $48M in the prior-year period — up 74.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $84M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CM Life Sciences, and consider following CMLF for alerts when major investors trade the stock.